Benha University
Banhā, Qalyubia Governorate, 15311, Egypt
NCT Number: NCT04848181
Perioperative bleeding is the most common complication related to transurethral resection of prostate, the aim of the study is to compare the effect of pre-operative use of finasteride versus Cyproterone acetate on blood loss with mono polar TURP
Looking for future studies?
Notify MeMale
Interventional
Early Phase 1
Banhā, Qalyubia Governorate, 15311, Egypt
This prospective randomized controlled study to compare the effect of pre-operative use of finasteride versus Cyproterone acetate on blood loss with mono polar TURP
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
two weeks Cyproterone acetate administration before TURP
two weeks finasteride administration before TURP
no treatment received before TURP
Time frame: 24 hour post operative
measuring serum haemoglobin level at first post operative
Time frame: 24 hour post operative
measuring serum haematocrit value at first post operative
Time frame: immediately after surgery
assessment of the duration of the operation
Time frame: 2 weeks after drug intake
assesment of MVD of the prostate by histological examination using high power field microscope
Time frame: immediately after surgery
assessment of intraoperative blood loss during TURP
Benha University
Other
The Effect of Short Term Use of Finasteride Versus Cyproterone Acetate on Perioperative Blood Loss With Mono Polar Transurethral Resection of Prostate
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05443451
Genital Diseases, Genital Diseases, Male
Hong Kong
View Trial DetailsNCT07349147
Genital Diseases, Genital Diseases, Male
Gaziantep, Gazi̇antep, Turkey (Türkiye)
View Trial DetailsNCT07269652
Genital Diseases, Genital Diseases, Male
Seinäjoki, Finland
View Trial DetailsNCT06469125
Bladder Injury, Genital Diseases
Konya, Turkey (Türkiye)
View Trial Details